Table of Contents Author Guidelines Submit a Manuscript
International Journal of Microbiology
Volume 2012 (2012), Article ID 683450, 6 pages
http://dx.doi.org/10.1155/2012/683450
Research Article

Differential Adaptations of Methicillin-Resistant Staphylococcus aureus to Serial In Vitro Passage in Daptomycin: Evolution of Daptomycin Resistance and Role of Membrane Carotenoid Content and Fluidity

1Division of Infectious Diseases, Los Angeles Biomedical Research Institute, Harbor-University of California at Los Angeles (UCLA) Medical Center, Torrance, CA 90502, USA
2Cubist Pharmaceuticals, Lexington, MA 02421, USA
3Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA
4David Geffen School of Medicine UCLA, Los Angeles, CA 90095, USA

Received 31 May 2012; Accepted 1 July 2012

Academic Editor: Giuseppe Comi

Copyright © 2012 Nagendra N. Mishra et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Boucher, L. G. Miller, and R. R. Razonable, “Serious infections caused by methicillin-resistant Staphylococcus aureus,” Clinical Infectious Diseases, vol. 51, no. 2, pp. S183–S197, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. N. N. Mishra, J. McKinnell, M. R. Yeaman et al., “In Vitro cross-resistance to daptomycin and host defense cationic antimicrobial peptides in clinical methicillin-resistant Staphylococcus aureus isolates,” Antimicrobial Agents and Chemotherapy, vol. 55, no. 9, pp. 4012–4018, 2011. View at Publisher · View at Google Scholar
  3. V. Cafiso, T. Bertuccio, D. Spina et al., “Modulating activity of vancomycin and daptomycin on the expression of autolysis cell-wall turnover and membrane charge genes in hVISA and VISA strains,” PLoS ONE, vol. 7, no. 1, Article ID e29573, 2012. View at Publisher · View at Google Scholar
  4. T. Jones, M. R. Yeaman, G. Sakoulas et al., “Failures in clinical treatment of Staphylococcus aureus infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding,” Antimicrobial Agents and Chemotherapy, vol. 52, no. 1, pp. 269–278, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Friedman, J. D. Alder, and J. A. Silverman, “Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus,” Antimicrobial Agents and Chemotherapy, vol. 50, no. 6, pp. 2137–2145, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. N. N. Mishra, S. J. Yang, A. Sawa et al., “Analysis of cell membrane characteristics of in vitro-selected daptomycin-resistant strains of methicillin-resistant Staphylococcus aureus,” Antimicrobial Agents and Chemotherapy, vol. 53, no. 6, pp. 2312–2318, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. S. J. Yang, B. N. Kreiswirth, G. Sakoulas et al., “Enhanced expression of dltabcd is associated with the development of daptomycin nonsusceptibuity in a clinical endocarditis isolate of Staphylococcus aureus,” Journal of Infectious Diseases, vol. 200, no. 12, pp. 1916–1920, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. U. Bertsche, C. Weidenmaier, D. Kuehner et al., “Correlation of daptomycin resistance in a clinical Staphylococcus aureus strain with increased cell wall teichoic acid production and D-alanylation,” Antimicrobial Agents and Chemotherapy, vol. 55, no. 8, pp. 3922–3928, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Mehta, A. X. Cuirolo, and K. B. Plata, “VraSR two-component regulatory system contributes to mprF-mediated decreased susceptibility to daptomycin in vivo-selected clinical strains of methicillin-resistant Staphylococcus aureus,” Antimicrobial Agents Chemotherapy, vol. 56, no. 1, pp. 92–102, 2012. View at Google Scholar
  10. A. Rubio, J. Moore, M. Varoglu et al., “LC-MS/MS characterization of phospholipid content in daptomycin-susceptible and-resistant isolates of Staphylococcus aureus with mutations in mprF,” Molecular Membrane Biology, vol. 29, no. 1, pp. 1–8, 2012. View at Publisher · View at Google Scholar
  11. S. J. Yang, C. C. Nast, N. N. Mishra, M. R. Yeaman, P. D. Fey, and A. S. Bayer, “Cell wall thickening is not a universal accompaniment of the daptomycin nonsusceptibility phenotype in Staphylococcus aureus: evidence for multiple resistance mechanisms,” Antimicrobial Agents and Chemotherapy, vol. 54, no. 8, pp. 3079–3085, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. N. R. Chamberlain, B. G. Mehrtens, Z. Xiong, F. A. Kapral, J. L. Boardman, and J. I. Rearick, “Correlation of carotenoid production, decreased membrane fluidity, and resistance to oleic acid killing in Staphylococcus aureus 18Z,” Infection and Immunity, vol. 59, no. 12, pp. 4332–4337, 1991. View at Google Scholar · View at Scopus
  13. N. N. Mishra, G. Y. Liu, M. R. Yeaman et al., “Carotenoid-related alteration of cell membrane fluidity impacts Staphylococcus aureus susceptibility to host defense peptides,” Antimicrobial Agents and Chemotherapy, vol. 55, no. 2, pp. 526–531, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Mukhopadhyay, W. Whitmire, Y. O. Xiong et al., “Reduced in vitro susceptibility of Staphylococcus aureus to thrombin-induced platelet microbicidal protein-1 (tPMP-1) is influenced by cell membrene phospholipid composition and asymmetry,” Microbiology, vol. 153, no. 4, pp. 1187–1197, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Sieradzki, T. Leski, J. Dick, L. Borio, and A. Tomasz, “Evolution of a vancomycin-intermediate Staphylococcus aureus strain in vivo: multiple changes in the antibiotic resistance phenotypes of a single lineage of methicillin-resistant S. aureus under the Impact of antibiotics administered for chemotherapy,” Journal of Clinical Microbiology, vol. 41, no. 4, pp. 1687–1693, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. S. J. Yang, Y. Q. Xiong, S. Boyle-Vavra, R. Daum, T. Jones, and A. S. Bayer, “Daptomycin-oxacillin combinations in treatment of experimental endocarditis caused by daptomycin-nonsusceptible strains of methicillin-resistant Staphylococcus aureus with evolving oxacillin susceptibility (the “seesaw effect”),” Antimicrobial Agents and Chemotherapy, vol. 54, no. 8, pp. 3161–3169, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Y. Peleg, S. Miyakis, D. V. Ward et al., “Whole genome characterization of the mechanisms of daptomycin resistance in clinical and laboratory derived isolates of Staphylococcus aureus,” PLoS ONE, vol. 7, no. 1, Article ID e28316, 2012. View at Publisher · View at Google Scholar
  18. S. Boyle-Vavra, M. Jones, B. L. Gourley et al., “Comparative genome sequencing of an isogenic pair of USA800 clinical methicillin-resistant Staphylococcus aureus isolates obtained before and after daptomycin treatment failure,” Antimicrobial Agents and Chemotherapy, vol. 55, no. 5, pp. 2018–2025, 2011. View at Publisher · View at Google Scholar · View at Scopus